News
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
13d
News-Medical.Net on MSNOnce-monthly obesity injection shows double-digit weight loss in major clinical trialResearchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...
Learn how simultaneous DSC-TGA (SDT) techniques uncover critical thermal behaviors in LFP lithium-ion battery cathodes.
While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...
The Nothing Phone 3 delivers one of the most unique experiences on a phone, but it falls short in a key area that stops its ...
The measure extending tax cuts and slashing the social safety net goes to President Trump for his signature, but the debate ...
These are the best smart scales to buy in every category, from Withings Body and Garmin Index S2 to Renpho Elis 1.
Several cancers are becoming more common in young adults, including testicular cancer, melanoma, and cervical cancer. Blood-related cancers like B-cell lymphomas and plasma cell neoplasms are also on ...
A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results